Alessandra
Spada is a PhD student in the Group for Functionalized Biomaterials, under the
supervision of Prof. Sandrine Gerber (EPFL, Lausanne), working on the surface
functionalization of harmonic nanoparticles (NPs) with targeting ligands for cancer
active targeting. She was a graduate research fellow in the Laboratory of
Polymers and Biomaterials, under the supervision of Prof. Nicola Tirelli (Instituto
Italiano di Tecnologia, Genoa, Italy) where she developed formulations of
chitosan/hyaluronic acid NPs and assessed the performance of the in vitro studies for the uptake and
internalization in microglia and human dermal fibroblasts. She completed her Master's thesis
at the Faculty of Pharmacy and Pharmaceutical Sciences, under the supervision
of Prof. Afsaneh Lavasanifar (University of Alberta, Edmonton, Canada), working
on the design, production and evaluation of albumin NPs for the delivery of a
beta-tubulin polymerization inhibitor as a novel chemotherapy formulation for
cancer treatment. She received her Master's degree in Bionanotechnology from
Politecnico di Torino (Turin, Italy) (110L/110) in 2020 and her Bachelor's degree
in Bioengineering and Biomedical Engineering from the same institution in 2018 (110L/110).
Alessandra
Spada is a PhD student in the Group for Functionalized Biomaterials, under the
supervision of Prof. Sandrine Gerber (EPFL, Lausanne), working on the surface
functionalization of harmonic nanoparticles (NPs) with targeting ligands for cancer
active targeting. She was a graduate research fellow in the Laboratory of
Polymers and Biomaterials, under the supervision of Prof. Nicola Tirelli (Instituto
Italiano di Tecnologia, Genoa, Italy) where she developed formulations of
chitosan/hyaluronic acid NPs and assessed the performance of the in vitro studies for the uptake and
internalization in microglia and human dermal fibroblasts. She completed her Master's thesis
at the Faculty of Pharmacy and Pharmaceutical Sciences, under the supervision
of Prof. Afsaneh Lavasanifar (University of Alberta, Edmonton, Canada), working
on the design, production and evaluation of albumin NPs for the delivery of a
beta-tubulin polymerization inhibitor as a novel chemotherapy formulation for
cancer treatment. She received her Master's degree in Bionanotechnology from
Politecnico di Torino (Turin, Italy) (110L/110) in 2020 and her Bachelor's degree
in Bioengineering and Biomedical Engineering from the same institution in 2018 (110L/110).